StockData
TAO Synergies Inc. logo

TAO Synergies Inc. (TAOX) shareholders

TAOXNasdaqFinance ServicesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 5/30117% above fair value
$1.87+0.01 (+0.54%)

Close on Nov 17, 2026Market cap $13.99MP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
9.5%
1M of 7M shares
Institutional holders
29
6 new, 2 sold out
Net institutional buying
0M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only

Shares held by institutions

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of TAOXValueChange% of portfolio
Vanguard Capital Management LLC118,4711.58%$441.90K+39,1020.00%
Citadel Advisors LLC83,1721.11%$310.23KNew0.00%
Geode Capital Management, LLC79,3741.06%$296.26K−9,2700.00%
Renaissance Technologies LLC78,8171.05%$293.99K−22,9830.00%
Summit Financial, LLC57,7600.77%$215.45K+14,4850.00%
Jane Street Group, LLC54,8540.73%$204.61KNew0.00%
BlackRock, Inc.45,8980.61%$171.20K+26,1450.00%
Hrt Financial LP40,0720.54%$149.00KNew0.00%
UBS Group AG32,7790.44%$122.27K+22,0290.00%
Vanguard Fiduciary Trust Co31,8890.43%$118.95K−13,5430.00%
State Street Corp25,2000.34%$94.00K+5,9000.00%
Morgan Stanley24,3590.33%$90.86K–0.00%
Northern Trust Corp13,9230.19%$51.93K+1,7970.00%
Dimensional Fund Advisors LP12,6190.17%$47.07K–0.00%
Ronald Blue Trust, Inc.2,8320.04%$10.56K–0.00%
Steward Partners Investment Advisory, LLC2,8000.04%$10.44K–0.00%
Massmutual Trust Co Fsb/Adv2,7000.04%$10.07K–0.00%
Tower Research Capital LLC (TRC)2,4130.03%$9.00K+2,3370.00%
PNC Financial Services Group, Inc.7500.01%$2.80K–0.00%
SBI Securities Co., Ltd.5200.01%$1.94KNew0.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 2026291M9.5%6 / 95 / 20M0M
Q1 2026250M6.3%8 / 54 / 80M0M
Q4 2025261M7.9%11 / 64 / 80M0M
Q3 2025230M4.7%14 / 51 / 30M0M
Q2 2025120M0.8%5 / 21 / 40M0M
Q1 2025110M0.7%3 / 41 / 00M0M
Q4 202480M0.3%1 / 21 / 10M0M
Q3 202480M0.0%3 / 12 / 20M0M
Q2 202480M0.1%8 / 00 / 00M0M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

12 funds held TAOX in Q2 2026, 65% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of TAOXValue% of fundAs of
Vanguard Extended Market Index Fund79,0991.06%$295.04K0.00%Jun 30, 2026
Fidelity Extended Market Index Fund36,3680.49%$152.75K0.00%May 31, 2026
iShares Micro-Cap ETF24,5270.33%$91.49K0.01%Jun 30, 2026
Fidelity Total Market Index Fund12,2420.16%$51.42K0.00%May 31, 2026
Dimensional U.S. Small Cap ETF11,1190.15%$36.58K0.00%Jul 31, 2026
Fidelity Series Total Market Index Fund9,8600.13%$41.41K0.00%May 31, 2026
Vanguard Total Stock Market Index Fund8,8720.12%$33.09K0.00%Jun 30, 2026
Fidelity Nasdaq Composite Index Fund7,0140.09%$29.46K0.00%May 31, 2026
1290 VT Micro Cap Portfolio1,6180.02%$6.04K0.00%Jun 30, 2026
U.S. Micro Cap Portfolio8000.01%$2.63K0.00%Jul 31, 2026
State Street Balanced Index Fund3980.01%$1.48K0.00%Jun 30, 2026
Blackstone Alternative Multi-Strategy Fund-300-0.00%-$1.12K-0.00%Jun 30, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Joshua SilvermanExecutive Chairman, Director217,9312.91%Nov 17, 2026
Alan J. TuchmanChief Medical Officer, Director3,9090.05%Feb 5, 2026
Robert WeinsteinChief Financial Officer16,5740.22%Nov 17, 2026
Bruce BernsteinDirector80,8971.08%Nov 17, 2026
William S. SingerDirector19,5660.26%Nov 17, 2026
Robert EphronDirector4,5000.06%Nov 17, 2026
Jonathan SchechterDirector22,6650.30%Oct 17, 2025

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Joshua Silverman
Executive Chairman, Director
Nov 13, 2026Award+131,250––217,931
Bruce Bernstein
Director
Nov 13, 2026Award+50,000––80,897
Robert Weinstein
Chief Financial Officer
Oct 17, 2025Tax withholding−4,000$7.23$28.92K16,574
Robert Weinstein
Chief Financial Officer
Oct 17, 2025Award+10,000––20,574
Bruce Bernstein
Director
Oct 17, 2025Award+25,000––40,897
Bruce Bernstein
Director
Oct 17, 2025Tax withholding−10,000$7.23$72.30K30,897
Joshua Silverman
Executive Chairman, Director
Oct 17, 2025Tax withholding−40,000$7.23$289.20K86,681
Joshua Silverman
Executive Chairman, Director
Oct 17, 2025Award+100,000––126,681
William S. Singer
Director
Oct 17, 2025Tax withholding−6,000$7.23$43.38K19,566
William S. Singer
Director
Oct 17, 2025Award+15,000––25,566
Robert Ephron
Director
Oct 17, 2025Tax withholding−3,000$7.23$21.69K4,500
Robert Ephron
Director
Oct 17, 2025Award+7,500––7,500
Jonathan Schechter
Director
Jun 30, 2025Award+21,575––22,665
Jonathan Schechter
Director
Jun 30, 2025Tax withholding−8,630$7.85$67.75K14,035
William S. Singer
Director
Jun 30, 2025Tax withholding−6,164$7.85$48.39K10,566
William S. Singer
Director
Jun 30, 2025Award+15,410––16,730
Joshua Silverman
Executive Chairman, Director
Jun 30, 2025Tax withholding−16,768$7.85$131.63K26,681
Joshua Silverman
Executive Chairman, Director
Jun 30, 2025Award+41,919––43,449
Bruce Bernstein
Director
Jun 30, 2025Award+24,657––25,760
Bruce Bernstein
Director
Jun 30, 2025Tax withholding−9,863$7.85$77.42K15,897
Alan J. Tuchman
Chief Medical Officer, Director
Jun 30, 2025Tax withholding−1,726$7.85$13.55K3,909
Alan J. Tuchman
Chief Medical Officer, Director
Jun 30, 2025Award+4,315––5,635
Robert Weinstein
Chief Financial Officer
Jun 30, 2025Award+15,410––16,738
Robert Weinstein
Chief Financial Officer
Jun 30, 2025Tax withholding−6,164$7.85$48.39K10,574
Daniel L. Alkon
President and CSO, Director
Dec 16, 2022Sale(10b5-1 plan)−19,688$1.17$23.03K35,546
William S. Singer
Director
Dec 16, 2022Sale(10b5-1 plan)−27,000$1.17$31.59K33,000
Joshua Silverman
Director
Dec 16, 2022Sale(10b5-1 plan)−19,012$1.17$22.24K38,238
Robert Weinstein
Chief Financial Officer
Dec 16, 2022Sale(10b5-1 plan)−27,000$1.17$31.59K33,198
Bruce Bernstein
Director
Dec 16, 2022Sale(10b5-1 plan)−22,500$1.17$26.33K27,578
Jonathan Schechter
Director
Dec 16, 2022Sale(10b5-1 plan)−20,250$1.17$23.69K28,500
Alan J. Tuchman
Chief Executive Officer, Director
Dec 16, 2022Sale(10b5-1 plan)−27,000$1.17$31.59K33,000
Daniel L. Alkon
President and CSO, Director
Jul 13, 2021Award+43,750––55,234
Joshua Silverman
Director
Jul 13, 2021Award+42,250––57,250
Alan J. Tuchman
Chief Executive Officer, Director
Jul 13, 2021Award+60,000––60,000
William S. Singer
Director
Jul 13, 2021Award+60,000––60,000
George Perry
Director
Jul 13, 2021Award+40,000––40,000
Jonathan Schechter
Director
Jul 13, 2021Award+45,000––48,750
Robert Weinstein
Chief Financial Officer
Jul 13, 2021Award+60,000––60,198
Bruce Bernstein
Director
Jul 13, 2021Award+50,000––50,078
Daniel L. Alkon
See Remarks, Director
Jul 13, 2021Award+80,000––91,484
Joshua Silverman
Director
Jul 13, 2021Award+90,000––105,000
Joshua Silverman
Director
Jun 14, 2021Buy+10,000$8.30$83.00K15,000
Daniel L. Alkon
Chief Scientific Officer, Director
Jun 14, 2021Buy+10,000$8.26$82.60K11,484

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
5.69%
0M shares short
Days to cover
3.7
At 0M shares a day
Change since last report
-24.5%
From 1M shares
Short volume, 20 days
44.9%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of TAO Synergies's stock actually held short. Settlement fails (shares not delivered on time) peaked at 43,936 shares on Sep 28, 2026 over the last 90 days.

See a number that looks wrong?